Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 54, Issue suppl_3, Pages S203-S213
Publisher
Oxford University Press (OUP)
Online
2012-03-20
DOI
10.1093/cid/cir923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Human Serum Albumin on Oritavancin In Vitro Activity against Enterococci
- (2009) G. A. McKay et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
- (2009) F. F. Arhin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization
- (2009) Oscar Domenech et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus
- (2009) Francis F. Arhin et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Time–kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes
- (2009) Francis F. Arhin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
- (2009) G. A. McKay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
- (2009) F. F. Arhin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
- (2009) Gary J. Patti et al. JOURNAL OF MOLECULAR BIOLOGY
- Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing
- (2008) F. F. Arhin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment by Time-Kill Methodology of the Synergistic Effects of Oritavancin in Combination with Other Antimicrobial Agents against Staphylococcus aureus
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters
- (2008) Francis F. Arhin et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin
- (2008) R. O'Connor et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
- (2008) Sung Joon Kim et al. JOURNAL OF MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started